The Siemens Healthineers SARS-CoV-2 Total Antibody Test will be available on the Atellica Solution immunoassay analyser with an initial time-to-result of 14 minutes. Credit: Business Wire.

Germany’s Siemens Healthineers has developed a laboratory-based total antibody test to identify individuals with past Covid-19 infections.

The test will help to identify the antibodies of SARS-CoV-2, the virus strain that causes the disease, in the individuals who have developed an immune response to the virus.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Currently, Siemens Healthineers is working to receive emergency use authorisation (EUA) from the US Food and Drug Administration (FDA).

The company aims to make the Covid-19 test available by late next month, while its manufacturing facility in Walpole, Massachusetts, US, is expected to deliver more than 25 million tests per month from June.

Siemens Healthineers Laboratory Diagnostics president Deepak Nath said: “Siemens Healthineers is working diligently to address the need for high-quality tests in the fight against Covid-19.

“This test is being designed with the precision and controls, sensitivity and specificity that laboratories have come to expect from our immunoassay tests.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The antibody test will be made available on the Atellica Solution immunoassay analyser. This equipment can run up to 440 tests per hour and will provide a result in approximately 14 minutes.

According to the company, the test is capable of identifying IgM and IgG antibodies and has demonstrated sensitivity and specificity of more than 99%.

Earlier, Abbott Laboratories and Switzerland’s Roche announced a plan to deliver antibody tests.

Abbott aims to deliver 20 million antibody tests per month by June.

Globally, Covid-19 virus has infected more than 2.7 million and nearly 191,000 people have lost their lives due to the pandemic.

Siemens Healthineers launched its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit earlier this month.